934554-58-2

Basic information

• Product Name: (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane
• Synonyms: (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane;6-Fluorospiro[chroman-2,1'-cyclobutan]-4-amine
• CAS NO: 934554-58-2
• Molecular Formula: C12H14FNO
• Molecular Weight: 207.2440632
• Mol File: 934554-58-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane(934554-58-2)
• EPA Substance Registry System: (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane(934554-58-2)

Safety Data

• Hazardous Substances Data: 934554-58-2(Hazardous Substances Data)

Usage

General Description

(+/-)-4-amino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane is a chemical compound with a spiro ring structure that contains a fluoro group and an amino group. It is a derivative of 1-benzopyran and cyclobutane, and exists in a racemic mixture of two enantiomers. (+/-)-4-aMino-3,4-dihydro-6-fluoro-spiro[2H-1-benzopyran-2,1'-cyclobutane has potential pharmacological properties and has been studied as a potential drug candidate for various medical conditions. Its spiro ring structure and fluorine substituent make it a unique and interesting compound for further research and development.

Upstream product

• 934554-57-1 6-fluorospiro[chroman-2,1'-cyclobutan]-4-one 
• 1144501-14-3 (E)-6-fluorospiro[chroman-2,1'-cyclobutan]-4-one O-methyl oxime 

Relevant articles and documents

TRPV1 Antagonists

Disclosed herein are compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein X1, L, Rx, Ry, Rz, A, m, n, p, q, s, and positions a and b are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

TRPV1 ANTAGONISTS

Disclosed herein are compounds of formula (I), or pharmaceutically acceptable salts, solvates, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS

The present invention relates to substituted benzofused derivatives, which can be used as vanilloid receptor ligands, method of treating diseases, conditions and/or disorders modulated by vanilloid receptors with them, and processes for preparing them.